Baxter International is recalling its Colleague infusion pumps from the American market under an agreement with federal regulators that sought to fix problems like battery failures and software errors. The Food and Drug Administration said on April 23 that infusion pumps used to administer drugs and liquids were linked to more than 56,000 complaints of injuries, deaths, and malfunctions from 2005 to 2009. The Baxter Healthcare Corporation, the company's principal American subsidiary, has been under a consent decree with the FDA since June 2006 that allowed the agency to require a recall of the pumps, the company said.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
